Evidence map›Paper›PMID 39261976›Full record

ArticlePhysiological reports2024

Higher serum myostatin levels are associated with lower insulin sensitivity in adults with overweight/obesity.

Laura E Dichtel, Allison Kimball, Bryan Bollinger, Geetanjali Scarff, Anu V Gerweck, Miriam A Bredella, Melanie S Haines

Abstract read
In one paragraph

Article in Physiological reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Inflammation-Insulin Resistance Crosstalk and the Central Role of Myokines.International journal of molecular sciences · 2025
    Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Laura E DichtelNeuroendocrine Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Allison KimballNeuroendocrine Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Bryan BollingerNeuroendocrine Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Geetanjali ScarffNeuroendocrine Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Anu V GerweckNeuroendocrine Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Miriam A BredellaHarvard Medical School, Boston, Massachusetts, USA.
Melanie S HainesNeuroendocrine Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.ORCID 0000-0003-1002-4754

Funding

HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)UL1RR025758 · NCRR · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2008 to 2011
$91.4M
ROLE OF DIETARY CONSTITUENTS ON GENE EXPRESSION IN INTESTINAL EPITHELIUMP30DK040561 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Elizabeth Austen Lawson, Takara Leah Stanley · 1994 to 2026
$31.6M
TRAINING PROGRAM IN ENDOCRINOLOGY AND DIABETEST32DK007028 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Karen K Miller · 1986 to 2026
$18.5M
Skeletal Physiology Dysregulation in Obesity: The Role of Growth HormoneR01DK095792 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BREDELLA, MIRIAM ANTOINETTE, MILLER, KAREN K · 2013 to 2017
$3.2M
Relative Sarcopenia and Cardiometabolic Risk in Young Adults with ObesityK23DK115903 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI HAINES, MELANIE SCHORR · 2017 to 2021
$1.1M
The Growth Hormone and Insulin-like Growth Factor-1 Axis in Nonalcoholic Fatty Liver Disease and Nonalcoholic SteatohepatitisK23DK113220 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI DICHTEL, LAURA ELISABETH · 2017 to 2021
$1.1M
Bone Metabolism in Adolescents UndergoingBariatric SurgeryK24DK109940 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BREDELLA, MIRIAM ANTOINETTE · 2017 to 2021
$970k
Boston Area Diabetes Endocrinology Research Center (BADERC)HHS | National Institutes of Health (NIH) 1UL1TR001102HHS | National Institutes of Health (NIH) 8UL1TR000170HHS | National Institutes of Health (NIH) K23DK113220HHS | National Institutes of Health (NIH) K23DK115903HHS | National Institutes of Health (NIH) K24DK109940HHS | National Institutes of Health (NIH) M01-RR-01066HHS | National Institutes of Health (NIH) R01DK095792HHS | National Institutes of Health (NIH) T32DK007028HHS | National Institutes of Health (NIH) UL1RR025758NIDDK NIH HHS P30 DK040561
6 · The paper itself

Abstract

Myostatin inhibition improves insulin sensitivity in preclinical and clinical models; however, studies investigating the relationship between serum myostatin levels and insulin sensitivity are discrepant. Sensitive and specific myostatin LC-MS/MS assays are now available to accurately assess serum myostatin level in vivo. We sought to determine whether higher serum myostatin levels are independently associated with lower insulin sensitivity in adults with overweight/obesity. Participants included 74 adults, 20-65 years old, BMI ≥25 kg/m

Indexed as

Insulin ResistanceMyostatinObesityOverweightAdultAgedFemaleHumansMaleMiddle AgedMSTN protein, humanMyostatininsulin sensitivitymusclemyostatinobesity

Identifiers

PMID39261976
PMCPMC11390341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.